These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
(MARK ONE)
|
|
|
x
|
QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the quarterly period ended
December 31, 2010
|
|
|
OR
|
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
|
|
For the transition period from ______________ to ______________
|
|
|
NEVADA
|
46-0510685
|
|
(State or other jurisdiction
of incorporation or organization)
|
(IRS Employer
Identification Number)
|
|
6075 Longbow Drive, Suite 200, Boulder, Colorado
|
80301
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Large accelerated filer
o
|
Accelerated filer
o
|
|
Non-accelerated filer
o
(Do not check if smaller reporting company)
|
Smaller reporting company
x
|
|
PART I Financial Information
|
||
|
Item 1.
|
3
|
|
|
3
|
||
|
4
|
||
|
5
|
||
|
7
|
||
|
Item 2.
|
21
|
|
|
Item 3.
|
39
|
|
|
Item 4.
|
40
|
|
|
PART II Other Information
|
||
|
Item 1.
|
41
|
|
|
Item 1A.
|
41
|
|
|
Item 2.
|
41
|
|
|
Item 3.
|
41
|
|
|
Item 4.
|
41
|
|
|
Item 5.
|
41
|
|
|
Item 6.
|
42
|
|
|
43
|
||
|
December 31, 2010
|
March 31, 2010
|
|||||||
|
ASSETS
|
(Unaudited)
|
(Derived from Audited Statements)
|
||||||
|
Current assets
|
||||||||
|
Cash
|
$ | 790,246 | $ | 249,582 | ||||
|
Restricted cash
|
160,102 | 443,862 | ||||||
|
Accounts receivable, net of allowance for doubtful accounts of
$97,375 and $87,207 at December 31, 2010 and March 31,
2010, respectively
|
926,010 | 478,113 | ||||||
|
Other receivables
|
184,436 | 259,831 | ||||||
|
Inventory
|
3,922,125 | 3,493,732 | ||||||
|
Prepaid expenses and other
|
747,208 | 338,095 | ||||||
|
Total current assets
|
$ | 6,730,127 | $ | 5,263,215 | ||||
|
Property and equipment, net of accumulated depreciation of
$2,468,812 and $2,486,377 at December 31, 2010 and March 31,
2010, respectively
|
472,860 | 1,002,530 | ||||||
|
Other assets
|
||||||||
|
Intangible assets, net of $20,825 and $6,854 of accumulated
amortization at December 31, 2010 and March 31, 2010,
respectively
|
277,090 | 275,599 | ||||||
|
Deposits
|
190,131 | 240,145 | ||||||
|
Deferred debt issuance costs, net of accumulated amortization
of $512,163 and $486,791 at December 31, 2010 and March
31, 2010, respectively
|
1,713,859 | 62,291 | ||||||
|
Total other assets
|
$ | 2,181,080 | $ | 578,035 | ||||
|
Total Assets
|
$ | 9,384,067 | $ | 6,843,780 | ||||
|
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
|
||||||||
|
Current liabilities
|
||||||||
|
Notes payable
|
$ | 638,312 | $ | - | ||||
|
Notes payable – related party
|
318,513 | - | ||||||
|
Current portion – long term debt – related party
|
104,583 | 911,275 | ||||||
|
Current portion – long term debt
|
938,917 | 3,053,984 | ||||||
|
Accounts payable
|
2,192,061 | 3,354,703 | ||||||
|
Accrued expenses
|
898,320 | 1,449,977 | ||||||
|
Customer deposits
|
126,904 | 339,041 | ||||||
|
Deferred rent
|
28,391 | 40,773 | ||||||
|
Total current liabilities
|
$ | 5,246,001 | $ | 9,149,753 | ||||
|
Long term debt
|
3,537,577 | 1,020,957 | ||||||
|
Long term debt – related party
|
254,088 | - | ||||||
|
Stockholders' equity
|
||||||||
|
Preferred stock, $.001 par value, 20,000,000 shares authorized
and 7,586 shares issued and outstanding at December 31,
2010 and March 31, 2010
|
8 | 8 | ||||||
|
Common stock, $.001 par value, 500,000,000 shares authorized,
15,242,660 and 12,398,249 shares issued and outstanding at
December 31, 2010 and March 31, 2010, respectively
|
15,242 | 12,398 | ||||||
|
Additional paid-in capital
|
61,902,320 | 52,933,467 | ||||||
|
Accumulated (deficit)
|
(61,571,169 | ) | (56,272,803 | ) | ||||
|
Total Stockholders' Equity (Deficit)
|
$ | 346,401 | $ | (3,326,930 | ) | |||
|
Total Liabilities and Stockholders' Equity (Deficit)
|
$ | 9,384,067 | $ | 6,843,780 | ||||
|
Three Months ended
December 31,
|
Nine Months ended
December 31,
|
|||||||||||||||
|
2010
|
2009
|
2010
|
2009
|
|||||||||||||
|
Revenue
|
||||||||||||||||
|
Product sales
|
$ | 5,002,871 | $ | 7,939,248 | $ | 8,200,507 | $ | 14,204,890 | ||||||||
|
Operating expenses
|
||||||||||||||||
|
Cost of revenue
|
2,879,404 | 4,830,387 | 5,239,919 | 8,970,748 | ||||||||||||
|
Research and development
|
56,810 | 93,046 | 146,570 | 385,598 | ||||||||||||
|
Sales and marketing
|
1,328,326 | 2,369,726 | 2,738,613 | 4,777,624 | ||||||||||||
|
General and administrative
|
702,712 | 1,013,921 | 2,411,195 | 3,767,727 | ||||||||||||
|
Total operating expenses
|
$ | 4,967,252 | $ | 8,307,080 | $ | 10,536,297 | $ | 17,901,697 | ||||||||
|
Profit (loss) from operations
|
35,619 | (367,832 | ) | (2,335,790 | ) | (3,696,807 | ) | |||||||||
|
Other (income) expense, net
|
||||||||||||||||
|
Interest (income)
|
(38 | ) | (94 | ) | (8,568 | ) | (235 | ) | ||||||||
|
Interest expense
|
1,198,705 | 297,975 | 2,650,205 | 736,594 | ||||||||||||
|
Interest expense – related party
|
129,432 | 31,922 | 285,181 | 77,593 | ||||||||||||
|
Other (income) expense
|
147,282 | 13,032 | 35,757 | (973,106 | ) | |||||||||||
|
Total other (income) expense, net
|
1,475,381 | 342,835 | 2,962,575 | (159,154 | ) | |||||||||||
|
Net income (loss)
|
$ | (1,439,762 | ) | $ | (710,667 | ) | $ | (5,298,365 | ) | $ | (3,537,653 | ) | ||||
|
Net income (loss) per share, basic
|
$ | (0.09 | ) | $ | (0.06 | ) | $ | (0.39 | ) | $ | (0.28 | ) | ||||
|
Net income (loss) per share, diluted
|
$ | (0.09 | ) | $ | (0.06 | ) | $ | (0.39 | ) | $ | (0.28 | ) | ||||
|
Weighted average number of common shares
outstanding used to calculated basic net
income (loss) per share
|
15,242,660 | 12,398,249 | 13,461,788 | 12,618,432 | ||||||||||||
|
Effect of dilutive securities:
|
||||||||||||||||
|
Equity based compensation
|
- | - | - | - | ||||||||||||
|
Weighted average number of common shares
outstanding used to calculated diluted net
income per share
|
15,242,660 | 12,398,249 | 13,461,788 | 12,618,432 | ||||||||||||
|
Nine months ended
December 31,
|
||||||||
|
2010
|
2009
|
|||||||
|
Cash flows from operating activities:
|
||||||||
|
Net (loss)
|
$ | (5,298,365 | ) | $ | (3,537,653 | ) | ||
|
Adjustments to reconcile net (loss) to cash (used) by operations:
|
||||||||
|
Issuance of common stock and options under equity compensation plans
|
68,255 | 418,825 | ||||||
|
Issuance of common stock not under equity compensation plans
|
-- | -- | ||||||
|
Issuance of warrants related to debt
|
-- | 29,802 | ||||||
|
Depreciation and amortization expense
|
576,970 | 649,843 | ||||||
|
Loss from disposal of fixed assets
|
73,292 | -- | ||||||
|
Allowance for bad debt
|
10,178 | (1,211,684 | ) | |||||
|
Amortization of debt issuance costs
|
575,083 | 176,420 | ||||||
|
Gain on forgiveness of accounts payable
|
-- | (807,310 | ) | |||||
| Loss from revision of vendor payment agreement | 105,591 | -- | ||||||
|
Amortization of convertible debentures, beneficial conversion feature
|
754,266 | -- | ||||||
|
Amortization of convertible debentures, beneficial conversion feature -
related party
|
102,507 | -- | ||||||
|
Interest expense from warrants issued with convertible debentures
|
702,056 | -- | ||||||
|
Interest expense from warrants issued with convertible debentures –
related party
|
92,898 | -- | ||||||
|
Change in assets and liabilities:
|
||||||||
|
(Increase) decrease in accounts receivable
|
(458,075 | ) | 721,615 | |||||
|
Decrease in other receivable
|
75,395 | 167,154 | ||||||
|
(Increase) decrease in inventory
|
(428,393 | ) | 3,191,163 | |||||
|
(Increase) decrease in other current assets
|
(409,113 | ) | 75,530 | |||||
|
(Increase) decrease in deposits
|
50,014 | (63,064 | ) | |||||
|
(Decrease) in accounts payable
|
(1,218,233 | ) | (1,227,923 | ) | ||||
|
Increase (decrease) in accrued expenses
|
109,789 | (905,173 | ) | |||||
|
Increase in accrued interest
|
277,953 | 75,965 | ||||||
|
Increase (decrease) in accrued interest-related party
|
33,800 | (15,813 | ) | |||||
|
Increase (decrease) in customer deposits
|
(212,137 | ) | 213,141 | |||||
|
(Decrease) in deferred rent
|
(12,382 | ) | (12,382 | ) | ||||
|
Net cash (used) by operating activities
|
$ | (4,428,651 | ) | $ | (2,061,544 | ) | ||
|
Cash flows from investing activities:
|
||||||||
|
(Increase) decrease in restricted cash
|
283,760 | (176 | ) | |||||
|
Purchases of equipment
|
(106,623 | ) | (74,292 | ) | ||||
|
Patent expenses
|
(15,462 | ) | (39,269 | ) | ||||
|
Net cash provided (used) by investing activities
|
$ | 161,675 | $ | (113,737 | ) | |||
|
Cash flows from financing activities:
|
||||||||
|
(Increase) in prepaid debt issuance costs
|
(678,051 | ) | (87,500 | ) | ||||
|
Proceeds from long term debt borrowings
|
1,069,677 | 11,010,924 | ||||||
|
Proceeds from long term debt borrowings-related party
|
-- | 655,000 | ||||||
|
Repayments of long term debt borrowings
|
(2,219,678 | ) | (13,538,418 | ) | ||||
|
Repayments of long term debt borrowings-related party
|
(132,033 | ) | -- | |||||
|
Proceeds from the issuance of convertible debt
|
5,485,000 | -- | ||||||
|
Proceeds from the issuance of convertible debt-related party
|
300,000 | -- | ||||||
|
Proceeds from notes payable
|
1,050,000 | -- | ||||||
|
Proceeds from notes payable -related party
|
450,000 | -- | ||||||
|
Repayments of notes payable
|
(371,806 | ) | -- | |||||
|
Repayments of notes payable-related party
|
(114,010 | ) | -- | |||||
|
Proceeds from the exercise of stock options
|
-- | 20 | ||||||
|
Proceeds from the issuance of preferred stock
|
-- | 4,441,537 | ||||||
|
Principal payments on capital leases
|
(31,459 | ) | (85,517 | ) | ||||
|
Net cash provided by financing activities
|
$ | 4,807,640 | $ | 2,396,046 | ||||
|
Net increase (decrease) in cash
|
540,664 | 220,765 | ||||||
|
Cash, beginning of period
|
249,582 | 332,698 | ||||||
|
Cash, end of period
|
$ | 790,246 | $ | 553,463 | ||||
|
Nine Months Ended
December 31,
|
||||||||
|
2010
|
2009
|
|||||||
|
Interest paid
|
$ | 287,783 | $ | 293,765 | ||||
|
Income taxes paid
|
$ | - | $ | - | ||||
|
Supplemental disclosure of non-cash investing and financing activities:
|
||||||||
|
Conversion of related party debt to equity
|
$ | - | $ | 1,200,000 | ||||
|
Conversion of accounts payable to equity
|
$ | - | $ | 1,043,000 | ||||
|
Increase of notes receivable for equity
|
$ | - | $ | 139,000 | ||||
|
Increase of notes receivable, related party for equity
|
$ | - | $ | 762,000 | ||||
|
Decrease of notes receivable, related party for equity as debt payment
|
$ | - | $ | 50,000 | ||||
|
Modification of accrued expenses to equity
|
$ | - | $ | 89,000 | ||||
|
Modification of accounts payable to long term debt
|
$ | - | $ | 1,386,040 | ||||
|
Modification of debt to convertible debt
|
$ | 475,000 | $ | - | ||||
|
Modification of related party debt to related party convertible debt
|
$ | 656,406 | $ | - | ||||
|
Modification of accrued interest to convertible debt
|
$ | 231,567 | $ | - | ||||
|
Modification of related party accrued interest to related party
convertible debt
|
$ | 50,789 | $ | - | ||||
|
Modification of accounts payable to convertible debt
|
$ | 50,000 | $ | - | ||||
|
Conversion of convertible note to common stock
|
$ | 275,000 | ||||||
|
Conversion of accrued interest to common stock
|
$ | 9,441 | $ | - | ||||
|
Warrants issued to placement agent as a cost of debt issuance
|
$ | 1,548,600 | $ | - | ||||
|
Conversion of accrued expenses to debt
|
$ | 661,446 | ||||||
|
1.
|
Description of the Business
|
|
2.
|
Liquidity and Basis of Presentation
|
|
Level 1:
|
Quoted prices (unadjusted) in active markets for identical assets or liabilities.
|
|
|
Level 2:
|
Observable market-based inputs, other than quoted prices in active markets for identical assets. or liabilities.
|
|
|
Level 3:
|
Unobservable inputs.
|
|
December 31,
|
March 31,
|
|||||||
|
2010
|
2010
|
|||||||
|
Finished goods
|
$
|
2,682,973
|
$
|
2,515,451
|
||||
|
Raw materials
|
1,239,152
|
978,281
|
||||||
|
$
|
3,922,125
|
$
|
3,493,732
|
|||||
|
3.
|
Notes Payable, Long Term Debt and Current Portion – Long Term Debt
|
|
4.
|
Equity Compensation Plans
|
|
OPTIONS OUTSTANDING
|
OPTIONS EXERCISABLE
|
||||||||||||||||||||||||||||
|
Weighted-
|
Weighted-
|
||||||||||||||||||||||||||||
|
average
|
Weighted-
|
average
|
Weighted-
|
||||||||||||||||||||||||||
|
Remaining
|
average
|
Aggregate |
Remaining
|
average
|
Aggregate | ||||||||||||||||||||||||
|
Exercise
|
Contractual
|
Exercise
|
Intrinsic |
Contractual
|
Exercise
|
Intrinsic | |||||||||||||||||||||||
|
price range
|
Options
|
Life (years)
|
Price
|
Value |
Options
|
Life (years)
|
Price
|
Value | |||||||||||||||||||||
|
Over $0.00 to $0.50
|
10,485,425 | 4.37 | $ | 0.10 | 2,817,785 | 2.91 | $ | 0.14 | |||||||||||||||||||||
|
Over $0.50 to $2.50
|
- | - | $ | - | - | - | $ | - | |||||||||||||||||||||
|
Over $2.50 to $5.00
|
- | - | $ | - | - | - | $ | - | |||||||||||||||||||||
|
Over $5.00 to $5.50
|
409,984 | 0.26 | $ | 5.00 | 409,984 | 0.26 | $ | 5.00 | |||||||||||||||||||||
|
Over $5.50
|
25,000 | 1.22 | $ | 5.90 | 25,000 | 1.22 | $ | 5.90 | |||||||||||||||||||||
| 10,920,409 | 4.21 | $ | 0.29 | $ |
--
|
3,252,769 | 2.56 | $ | 0.80 | $ |
--
|
||||||||||||||||||
|
5.
|
Income Taxes
|
|
6.
|
Related Party Transactions
|
|
7.
|
Stockholders’ Equity
|
|
Weighted
|
||||||||||||
|
Warrants
|
Average
|
Aggregate
|
||||||||||
|
Outstanding
|
Exercise Price
|
Intrinsic Value
|
||||||||||
|
Outstanding, April 1, 2010
|
6,273,390 | $ | 4.88 | - | ||||||||
|
Granted
|
90,573,333 | 0.19 | ||||||||||
|
Exercised
|
- | - | ||||||||||
|
Expired
|
(514,996 | ) | 5.02 | |||||||||
|
Outstanding, December 31, 2010
|
96,331,727 | $ | 0.47 | $ | 0.00 | |||||||
|
Weighted Average
|
||||||||||
|
Warrants
Outstanding
|
Exercise
Price
|
Remaining
Life (Yrs)
|
||||||||
| 7,020,000 | $ | 0.10 | 4.41 | |||||||
| 833,333 | $ | 0.18 | 4.83 | |||||||
| 82,720,000 | $ | 0.20 | 4.43 | |||||||
| 1,320,000 | $ | 0.25 | 3.81 | |||||||
| 325,000 | $ | 1.00 | 3.13 | |||||||
| 122,639 | $ | 2.00 | 0.63 | |||||||
| 16,000 | $ | 2.07 | 2.50 | |||||||
| 454,000 | $ | 6.00 | 0.44 | |||||||
| 1,937,299 | $ | 6.25 | 0.16 | |||||||
| 50,000 | $ | 6.96 | 1.58 | |||||||
| 746,956 | $ | 7.50 | 1.19 | |||||||
| 720,000 | $ | 8.00 | 3.68 | |||||||
| 66,500 | $ | 8.25 | 3.68 | |||||||
| 96,331,727 | $ | 0.47 | 4.28 | |||||||
|
Weighted
|
||||||||
|
Average
|
||||||||
|
Warrants Outstanding
|
Exercise Price
|
|||||||
|
Outstanding, April 1, 2010
|
4,164 | $ | 1,250 | |||||
|
Granted
|
-- | $ | -- | |||||
|
Exercised
|
-- | $ | -- | |||||
|
Expired
|
-- | $ | -- | |||||
|
Outstanding, December 31, 2010
|
4,164 | $ | 1,250 | |||||
|
8.
|
Subsequent Events
|
|
Three Months Ended December 31,
|
||||||||
|
2010
|
2009
|
|||||||
|
Revenue
|
||||||||
|
Product sales – retail, net
|
27.3
|
%
|
46.0
|
%
|
||||
|
Product sales – direct to consumer, net
|
71.2
|
%
|
52.4
|
%
|
||||
|
Product sales – international
|
1.5
|
%
|
1.6
|
%
|
||||
|
Total sales
|
100.0
|
%
|
100.0
|
%
|
||||
|
Operating expenses
|
||||||||
|
Cost of revenue
|
57.6
|
%
|
60.8
|
%
|
||||
|
Research and development
|
1.1
|
%
|
1.2
|
%
|
||||
|
Sales and marketing
|
26.6
|
%
|
29.8
|
%
|
||||
|
General and administrative
|
14.0
|
%
|
12.8
|
%
|
||||
|
Total operating expenses
|
99.3
|
%
|
104.6
|
%
|
||||
|
Profit/(loss) from operations
|
0.7
|
%
|
-4.6
|
%
|
||||
|
Three Months Ended December 31,
|
||||||||
|
Product Revenue
|
2010
|
2009
|
||||||
|
Retail, net
|
$ | 1,366,060 | $ | 3,649,483 | ||||
|
Direct to consumer, net
|
3,563,597 | 4,159,984 | ||||||
|
International
|
73,214 | 129,781 | ||||||
|
Total
|
$ | 5,002,871 | $ | 7,939,248 | ||||
|
Three Months Ended December 31,
|
||||||||
|
2010
|
2009
|
|||||||
|
Product Revenue
|
||||||||
|
AeroGardens
|
$
|
3,251,866
|
$
|
5,662,031
|
||||
|
Seed kits and accessories
|
1,751,005
|
2,277,217
|
||||||
|
Total
|
$
|
5,002,871
|
$
|
7,939,248
|
||||
|
% of Total Revenue
|
||||||||
|
AeroGardens
|
65.0
|
%
|
71.3
|
%
|
||||
|
Seed kits and accessories
|
35.0
|
%
|
28.7
|
%
|
||||
|
Total
|
100.0
|
%
|
100.0
|
%
|
||||
|
Three Months Ended December 31,
|
||||||||
|
2010
|
2009
|
|||||||
|
Advertising
|
$ | 672,899 | $ | 1,221,286 | ||||
|
Personnel
|
373,319 | 570,195 | ||||||
|
Sales commissions
|
57,975 | 163,947 | ||||||
|
Trade Shows
|
7,518 | 5,923 | ||||||
|
Other
|
216,615 | 408,375 | ||||||
| $ | 1,328,326 | $ | 2,369,726 | |||||
|
Three Months Ended December 31,
|
||||||||
|
2010
|
2009
|
|||||||
|
Operating Profit (Loss)
|
$ | 35,619 | $ | (367,832 | ) | |||
|
Add Back Non-Cash Items
:
|
||||||||
|
Depreciation
|
173,957 | 212,947 | ||||||
|
Amortization
|
4,357 | (14,092 | ) | |||||
|
Total Non-Cash Items
|
178,314 | 198,855 | ||||||
|
EBITDA
|
$ | 213,933 | $ | (168,977 | ) | |||
|
Nine Months Ended
December 31,
|
||||||||
| 2010 |
2009
|
|||||||
|
Revenue
|
||||||||
|
Product sales - retail, net
|
22.5
|
%
|
44.7
|
%
|
||||
|
Product sales - direct to consumer, net
|
75.4
|
%
|
53.1
|
%
|
||||
|
Product sales – international, net
|
2.1
|
%
|
2.2
|
%
|
||||
|
Total sales
|
100.0
|
%
|
100.0
|
%
|
||||
|
Operating expenses
|
||||||||
|
Cost of revenue
|
63.9
|
%
|
63.2
|
%
|
||||
|
Research and development
|
1.8
|
%
|
2.7
|
%
|
||||
|
Sales and marketing
|
33.4
|
%
|
33.6
|
%
|
||||
|
General and administrative
|
29.4
|
%
|
26.5
|
%
|
||||
|
Total operating expenses
|
128.5
|
%
|
126.0
|
%
|
||||
|
Profit/(loss) from operations
|
-28.5
|
%
|
-26.0
|
%
|
||||
|
Nine Months Ended
December 31,
|
||||||||
|
Product Revenue
|
2010
|
2009
|
||||||
|
Retail, net
|
$ | 1,845,011 | $ | 6,349,527 | ||||
|
Direct to consumer, net
|
6,182,138 | 7,545,368 | ||||||
|
International, net
|
173,358 | 309,995 | ||||||
|
Total
|
$ | 8,200,507 | $ | 14,204,890 | ||||
|
Nine Months Ended
December 31,
|
||||||||
|
2010
|
2009
|
|||||||
|
Product Revenue
|
||||||||
|
AeroGardens
|
$
|
4,871,316
|
$
|
9,589,778
|
||||
|
Seed kits and accessories
|
3,329,191
|
4,615,112
|
||||||
|
Total
|
$
|
8,200,507
|
$
|
14,204,890
|
||||
|
% of Total Revenue
|
||||||||
|
AeroGardens
|
59.4
|
%
|
67.5
|
%
|
||||
|
Seed kits and accessories
|
40.6
|
%
|
32.5
|
%
|
||||
|
Total
|
100.0
|
%
|
100.0
|
%
|
||||
|
Nine Months Ended
December 31,
|
||||||||
|
2010
|
2009
|
|||||||
|
Advertising
|
$ | 1,023,402 | $ | 1,870,455 | ||||
|
Personnel
|
1,069,750 | 1,803,273 | ||||||
|
Sales commissions
|
77,376 | 304,054 | ||||||
|
Trade shows
|
7,518 | 37,031 | ||||||
|
All other
|
560,567 | 762,811 | ||||||
| $ | 2,738,613 | $ | 4,777,624 | |||||
|
Nine Months Ended
December 31,
|
||||||||
|
2010
|
2009
|
|||||||
|
Operating Loss
|
$ | (2,335,790 | ) | $ | (3,696,807 | ) | ||
|
Add Back Non-Cash Items
:
|
||||||||
|
Depreciation
|
562,999 | 647,458 | ||||||
|
Amortization
|
13,971 | 2,383 | ||||||
|
Total Non-Cash Items
|
576,970 | 649,841 | ||||||
|
EBITDA
|
$ | (1,758,820 | ) | $ | (3,046,966 | ) | ||
|
·
|
fund our operations and working capital requirements,
|
|
·
|
develop and execute our product development and market introduction plans,
|
|
·
|
execute our sales and marketing plans,
|
|
·
|
fund research and development efforts, and
|
|
·
|
pay for debt obligations as they come due.
|
|
·
|
our cash of $950,348 ($160,102 of which was restricted as collateral for letters of credit and other corporate obligations) as of December 31, 2010,
|
|
·
|
our cash of $595,324 ($96,690 of which is restricted as collateral for letters of credit and other corporate obligations) as of February 9, 2011,
|
|
·
|
continued support of, and extensions of credit by, our suppliers and lenders,
|
|
·
|
our historical pattern of increased sales between September and March, and lower sales volume from April through August,
|
|
·
|
the level of spending necessary to support our planned initiatives, and
|
|
·
|
our sales to consumers, retailers, and international distributors, and the resulting cash flow from operations, which will depend in great measure on the success of our direct-to-consumer initiatives.
|
|
·
|
the effectiveness of our consumer-focused marketing efforts in generating both direct-to-consumer sales, and sales to consumers by our retailer customers,
|
|
·
|
uncertainty regarding the impact of macroeconomic conditions on consumer spending,
|
|
·
|
uncertainty regarding the capital markets and on our access to sufficient capital to support our current and projected scale of operations,
|
|
·
|
the seasonality of our business, in which we have historically experienced higher sales volume during the fall and winter months (September through March), and
|
|
·
|
a timely, uninterrupted supply of product from our third-party manufacturing suppliers in China.
|
|
Exhibit
Number
|
Description
|
|
|
3.1
|
Articles of Incorporation of the Company (incorporated by reference to Exhibit 3.1 of our Current Report on Form 8-K/A-2, filed November 16, 2006).
|
|
|
3.2
|
Certificate of Amendment to Articles of Incorporation, dated June 25, 2002 (incorporated by reference to Exhibit 3.2 of our Current Report on Form 8-K/A-2, filed November 16, 2006).
|
|
|
3.3
|
Certificate of Amendment to Articles of Incorporation, dated November 3, 2002 (incorporated by reference to Exhibit 3.3 of our Current Report on Form 8-K/A-2, filed November 16, 2006).
|
|
|
3.4
|
Certificate of Change to Articles of Incorporation, dated January 31, 2005 (incorporated by reference to Exhibit 3.4 of our Current Report on Form 8-K/A-2, filed November 16, 2006).
|
|
|
3.5
|
Certificate of Amendment to Articles of Incorporation, dated July 27, 2005 (incorporated by reference to Exhibit 3.5 of our Current Report on Form 8-K/A-2, filed November 16, 2006).
|
|
|
3.6
|
Certificate of Amendment to Articles of Incorporation, dated February 24, 2006 (incorporated by reference to Exhibit 3.6 of our Current Report on Form 8-K/A-2, filed November 16, 2006).
|
|
|
3.7
|
Certificate of Amendment to Articles of Incorporation, certified May 3, 2010 (incorporated by reference to Exhibit 3.7 of our Quarterly Report on Form 10-Q for the quarter ended June 30, 2010, filed August 12, 2010).
|
|
|
3.8
|
Amended and Restated Bylaws (incorporated by reference to Exhibit 3.1 of our Current Report on Form 8-K, filed September 26, 2008).
|
|
|
3.9
|
Amendment to Bylaws (incorporated by reference to Exhibit 3.9 of our Form 10-K for the fiscal year ended March 31, 2009, filed on July 6, 2009).
|
|
|
3.10
|
Certificate of Designations of Series A Convertible Preferred Stock (incorporated by reference to Exhibit 3.7 of our Annual Report on Form 10-K for the fiscal year ended March 31, 2009, filed July 6, 2009).
|
|
|
3.11
|
Certificate of Amendment to Series A Convertible Preferred Stock Certificate of Designations, certified June 21, 2010 (incorporated by reference to Exhibit 3.11 of our Quarterly Report on Form 10-Q for the quarter ended June 30, 2010, filed August 12, 2010).
|
|
|
10.1
|
Form of 15% Secured Convertible Promissory Note or “Credit Card Note” (incorporated by reference to Exhibit 4.1 of our Current Report on Form 8-K, filed October 28, 2010).
|
|
|
10.2
|
Form of Credit Card Warrant (incorporated by reference to Exhibit 4.2 of our Current Report on Form 8-K, filed October 28, 2010).
|
|
|
10.3
|
Guaranty Agreement by Jack J. Walker, J. Michael Wolfe and H. MacGregor Clarke, dated October 21, 2010 (incorporated by reference to Exhibit 10.1 of our Current Report on Form 8-K, filed October 28, 2010).
|
|
|
10.4
|
Contribution Agreement by Jack J. Walker, J. Michael Wolfe and H. MacGregor Clarke, dated October 25, 2010 (incorporated by reference to Exhibit 10.2 of our Current Report on Form 8-K, filed October 28, 2010).
|
|
|
10.5
|
Indemnity Agreement by Jack J. Walker, J. Michael Wolfe and H. MacGregor Clarke, dated October 25, 2010 (incorporated by reference to Exhibit 10.3 of our Current Report on Form 8-K, filed October 28, 2010).
|
|
|
10.6
|
Escrow and Account Control Agreement dated October 21, 2010 (incorporated by reference to Exhibit 10.4 of our Current Report on Form 8-K, filed October 28, 2010).
|
|
|
10.7*
|
||
|
10.9
|
2005 Equity Compensation Plan, as amended and restated (incorporated by reference to Appendix A of our Definitive Information Statement on Schedule 14C, filed July 28, 2010).
|
|
|
31.1*
|
||
|
31.2*
|
||
|
32.1*
|
||
|
32.2*
|
|
*
|
Filed Herewith
|
|
AeroGrow International Inc.
|
||
|
Date: February 14, 2011
|
/s/Jack J. Walker
|
|
|
By: Jack J. Walker
|
||
|
Its: Chairman and Chief Executive Officer
(Principal Executive Officer) and Director
|
||
|
Date: February 14, 2011
|
/s/H. MacGregor Clarke
|
|
|
By: H. MacGregor Clarke
|
||
|
Its: Chief Financial Officer (Principal Financial Officer)
|
||
|
Date: February 14, 2011
|
/s/Grey H. Gibbs
|
|
|
By: Grey H. Gibbs
|
||
|
Its: Controller (Principal Accounting Officer)
|
||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|